These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
111 related articles for article (PubMed ID: 7939434)
1. Serum antibody titres to Shigella lipopolysaccharides and invasion plasmid antigens in healthy Costa Rican and Swedish women. Achí R; Mata L; Lindberg AA Scand J Infect Dis; 1994; 26(3):329-37. PubMed ID: 7939434 [TBL] [Abstract][Full Text] [Related]
2. Titres of class-specific antibodies against Shigella and Salmonella lipopolysaccharide antigens in colostrum and breast milk of Costa Rican, Swedish and Vietnamese mothers. Achí R; Dac Cam P; Forsum U; Karlsson K; Sáenz P; Mata L; Lindberg AA J Infect; 1992 Jul; 25(1):89-105. PubMed ID: 1522329 [TBL] [Abstract][Full Text] [Related]
3. Serum antibody responses against shigella lipopolysaccharides and invasion plasmid-coded antigens in shigella infected Swedish patients. Li A; Rong ZC; Ekwall E; Forsum U; Lindberg AA Scand J Infect Dis; 1993; 25(5):569-77. PubMed ID: 8284641 [TBL] [Abstract][Full Text] [Related]
4. Antibodies against invasion plasmid coded antigens of shigellae in human colostrum and milk. Cam PD; Achi R; Lindberg AA; Pál T Acta Microbiol Hung; 1992; 39(3-4):263-70. PubMed ID: 1343940 [TBL] [Abstract][Full Text] [Related]
5. Serum IgG antibody responses to Shigella invasion plasmid-coded antigens detected by immunoblot. Li A; Zhao CR; Ekwall E; Lindberg AA Scand J Infect Dis; 1994; 26(4):435-45. PubMed ID: 7984976 [TBL] [Abstract][Full Text] [Related]
6. Age-specific prevalence of serum antibodies to the invasion plasmid and lipopolysaccharide antigens of Shigella species in Chilean and North American populations. Van de Verg LL; Herrington DA; Boslego J; Lindberg AA; Levine MM J Infect Dis; 1992 Jul; 166(1):158-61. PubMed ID: 1607690 [TBL] [Abstract][Full Text] [Related]
7. Detection of antibodies to Shigella lipopolysaccharide in urine after natural Shigella infection or vaccination. Cohen D; Orr N; Robin G; Slepon R; Ashkenazi S; Ashkenazi I; Shemer J Clin Diagn Lab Immunol; 1996 Jul; 3(4):451-5. PubMed ID: 8807212 [TBL] [Abstract][Full Text] [Related]
8. Shigellosis in Vietnam: seroepidemiologic studies with use of lipopolysaccharide antigens in enzyme immunoassays. Lindberg AA; Cam PD; Chan N; Phu LK; Trach DD; Lindberg G; Karlsson K; Kärnell A; Ekwall E Rev Infect Dis; 1991; 13 Suppl 4():S231-7. PubMed ID: 2047643 [TBL] [Abstract][Full Text] [Related]
9. Prospective study of systemic and mucosal immune responses in dysenteric patients to specific Shigella invasion plasmid antigens and lipopolysaccharides. Oberhelman RA; Kopecko DJ; Salazar-Lindo E; Gotuzzo E; Buysse JM; Venkatesan MM; Yi A; Fernandez-Prada C; Guzman M; León-Barúa R Infect Immun; 1991 Jul; 59(7):2341-50. PubMed ID: 2050402 [TBL] [Abstract][Full Text] [Related]
10. Age-related prevalence of Shigella and Salmonella antibodies and their association with diarrhoeal diseases in Peruvian children. Nguyen BM; Lanata CF; Black RE; Gil AI; Kärnell A; Wretlind B Scand J Infect Dis; 1998; 30(2):159-64. PubMed ID: 9730303 [TBL] [Abstract][Full Text] [Related]
11. Immune response against lipopolysaccharide and invasion plasmid-coded antigens of shigellae in Vietnamese and Swedish dysenteric patients. Cam PD; Pál T; Lindberg AA J Clin Microbiol; 1993 Feb; 31(2):454-7. PubMed ID: 8432838 [TBL] [Abstract][Full Text] [Related]
12. Quantitative analysis of IgG class and subclass and IgA serum response to Shigella sonnei and Shigella flexneri 2a polysaccharides following vaccination with Shigella conjugate vaccines. Robin G; Keisari Y; Slepon R; Ashkenazi S; Cohen D Vaccine; 1999 Aug; 17(23-24):3109-15. PubMed ID: 10462247 [TBL] [Abstract][Full Text] [Related]
13. Shigella-specific antibodies in the first year of life among Zambian infants: A longitudinal cohort study. Chisenga CC; Bosomprah S; Simuyandi M; Mwila-Kazimbaya K; Chilyabanyama ON; Laban NM; Bialik A; Asato V; Meron-Sudai S; Frankel G; Cohen D; Chilengi R PLoS One; 2021; 16(5):e0252222. PubMed ID: 34043697 [TBL] [Abstract][Full Text] [Related]
15. Characterization and quantitative analysis of serum IgG class and subclass response to Shigella sonnei and Shigella flexneri 2a lipopolysaccharide following natural Shigella infection. Robin G; Cohen D; Orr N; Markus I; Slepon R; Ashkenazi S; Keisari Y J Infect Dis; 1997 May; 175(5):1128-33. PubMed ID: 9129076 [TBL] [Abstract][Full Text] [Related]
16. Safety and immunogenicity of improved Shigella O-specific polysaccharide-protein conjugate vaccines in adults in Israel. Passwell JH; Harlev E; Ashkenazi S; Chu C; Miron D; Ramon R; Farzan N; Shiloach J; Bryla DA; Majadly F; Roberson R; Robbins JB; Schneerson R Infect Immun; 2001 Mar; 69(3):1351-7. PubMed ID: 11179298 [TBL] [Abstract][Full Text] [Related]
17. Immunoglobulin subclass distribution and dynamics of Shigella-specific antibody responses in serum and stool samples in shigellosis. Islam D; Wretlind B; Ryd M; Lindberg AA; Christensson B Infect Immun; 1995 May; 63(5):2054-61. PubMed ID: 7729920 [TBL] [Abstract][Full Text] [Related]
18. Serum antibody to lipopolysaccharide antigens of Shigella species among U.S. military personnel deployed to Saudi Arabia and Kuwait during Operations Desert Shield and Desert Storm. Hyams KC; Malone JD; Bourgeois AL; Hawkins R; Hale TL; Murphy JR Clin Diagn Lab Immunol; 1995 Nov; 2(6):700-3. PubMed ID: 8574833 [TBL] [Abstract][Full Text] [Related]